메뉴 건너뛰기




Volumn 5, Issue 4, 2010, Pages 325-333

Diagnosis, laboratory aspects and management of acquired hemophilia A

Author keywords

Acquired hemophilia; Autoimmune disorder; Factor VIII inhibitor; Hemostatic therapy; Immunosuppressive therapy

Indexed keywords

BLOOD CLOTTING FACTOR 8;

EID: 77955019955     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-010-0380-y     Document Type: Review
Times cited : (39)

References (49)
  • 1
    • 0037394016 scopus 로고    scopus 로고
    • Acquired hemophilia: Review and meta-analysis focused on the therapy and prognostic factors
    • Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A (2003) Acquired hemophilia: review and meta-analysis focused on the therapy and prognostic factors. Br J Haematol 121: 21.
    • (2003) Br J Haematol , vol.121 , pp. 21
    • Delgado, J.1    Jimenez-Yuste, V.2    Hernandez-Navarro, F.3    Villar, A.4
  • 2
    • 47649105365 scopus 로고    scopus 로고
    • Laboratory, clinical and therapeutic aspects of acquired hemophilia A
    • Franchini M, Targher G, Montagnana M, Lippi G (2008) Laboratory, clinical and therapeutic aspects of acquired hemophilia A. Clin Chim Acta 395: 14-18.
    • (2008) Clin Chim Acta , vol.395 , pp. 14-18
    • Franchini, M.1    Targher, G.2    Montagnana, M.3    Lippi, G.4
  • 4
    • 33847411624 scopus 로고    scopus 로고
    • Acquired hemophilia A in the United Kingdom: A 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctor's Organization
    • Collins PW, Hirsch S, Baglin TP et al (2007) Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctor's Organization. Blood 109: 1870-1877.
    • (2007) Blood , vol.109 , pp. 1870-1877
    • Collins, P.W.1    Hirsch, S.2    Baglin, T.P.3
  • 5
    • 47649123860 scopus 로고    scopus 로고
    • Acquired factor VIII inhibitors
    • Franchini M, Lippi G (2008) Acquired factor VIII inhibitors. Blood 112: 250-255.
    • (2008) Blood , vol.112 , pp. 250-255
    • Franchini, M.1    Lippi, G.2
  • 6
    • 77955040908 scopus 로고    scopus 로고
    • Lévesque H, Collins P, Baudo F, Huth-Kuhne A, Knoebl P, Marco P, Nemes L, Tengborn L (2009) Acquired haemophilia: descriptive data of the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost 7 (suppl 2): abstr 604.
  • 7
    • 0029841857 scopus 로고    scopus 로고
    • Acquired hemophilia A: A rare complication of Sjögren's syndrome
    • Vignes S, Le Moing V, Meekel P et al (1996) Acquired hemophilia A: a rare complication of Sjögren's syndrome. Clin Exp Rheumatol 14: 559-560.
    • (1996) Clin Exp Rheumatol , vol.14 , pp. 559-560
    • Vignes, S.1    Le Moing, V.2    Meekel, P.3
  • 8
    • 0019501541 scopus 로고
    • A survey of 215 non-hemophilic patients with inhibitors to factor VIII
    • Green D, Lechner K (1981) A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 45: 200-203.
    • (1981) Thromb Haemost , vol.45 , pp. 200-203
    • Green, D.1    Lechner, K.2
  • 9
    • 0028835505 scopus 로고
    • Post-partum factor VIII inhibitors: A review of the literature with special reference to the value of steroid and immunosuppressive treatment
    • Hauser I, Schneider B, Lechner K (1995) Post-partum factor VIII inhibitors: a review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thromb Haemost 73: 1-5.
    • (1995) Thromb Haemost , vol.73 , pp. 1-5
    • Hauser, I.1    Schneider, B.2    Lechner, K.3
  • 10
    • 0037333872 scopus 로고    scopus 로고
    • Acquired factor VIII inhibitors in pregnancy: Data from the Italian Haemophilia Registry relevant to clinical practice
    • Italian Association of Hemophilia Centers (AICE)
    • Italian Association of Hemophilia Centers (AICE) (2003) Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Registry relevant to clinical practice. BJOG 110: 311-314.
    • (2003) Bjog , vol.110 , pp. 311-314
  • 11
    • 34147189996 scopus 로고    scopus 로고
    • Drug-induced anti-factor VIII antibodies: A systematic review
    • Franchini M, Capra M, Nicolini N et al (2007) Drug-induced anti-factor VIII antibodies: a systematic review. Med Sci Monit 13: RA55-RA61.
    • (2007) Med Sci Monit , vol.13
    • Franchini, M.1    Capra, M.2    Nicolini, N.3
  • 12
    • 42749089017 scopus 로고    scopus 로고
    • Acquired factor VIII inhibitors in onco-hematology: A systematic review
    • Franchini M, Targher G, Manzato F, Lippi G (2008) Acquired factor VIII inhibitors in onco-hematology: a systematic review. Crit Rev Oncol Hematol 66: 194-199.
    • (2008) Crit Rev Oncol Hematol , vol.66 , pp. 194-199
    • Franchini, M.1    Targher, G.2    Manzato, F.3    Lippi, G.4
  • 14
    • 0028837315 scopus 로고
    • The Nijmegen modification of the Bethesda assay for factor VIII: C inhibitors: Improve specificity and reliability
    • Verbruggen B, Novakova I, Wessel H, Boezeman J, van den Berg M, Mauser-Bunschoten E (1995) The Nijmegen modification of the Bethesda assay for factor VIII: C inhibitors: improve specificity and reliability. Thromb Hemost 73: 247-251.
    • (1995) Thromb Hemost , vol.73 , pp. 247-251
    • Verbruggen, B.1    Novakova, I.2    Wessel, H.3    Boezeman, J.4    van den Berg, M.5    Mauser-Bunschoten, E.6
  • 16
    • 0003042160 scopus 로고
    • Laboratory tests for factor VIII inhibitor, their variation, significance and interpretation
    • Kasper CK (1991) Laboratory tests for factor VIII inhibitor, their variation, significance and interpretation. Blood Coagul Fibrinolysis 2: 7-10.
    • (1991) Blood Coagul Fibrinolysis , vol.2 , pp. 7-10
    • Kasper, C.K.1
  • 17
    • 0033678960 scopus 로고    scopus 로고
    • Acquired factor VIII autoantibody inhibitors: Current concept and potential therapeutic strategies for the future
    • Kessler CM (2000) Acquired factor VIII autoantibody inhibitors: current concept and potential therapeutic strategies for the future. Haematologica 85(Suppl): 57-63.
    • (2000) Haematologica , vol.85 , Issue.SUPPL. , pp. 57-63
    • Kessler, C.M.1
  • 18
    • 34247876261 scopus 로고    scopus 로고
    • Treatment of acquired hemophilia A
    • Collins PW (2007) Treatment of acquired hemophilia A. J Thromb Haemost 5: 893-900.
    • (2007) J Thromb Haemost , vol.5 , pp. 893-900
    • Collins, P.W.1
  • 19
    • 0012693663 scopus 로고    scopus 로고
    • The treatment of bleeding in acquired hemophilia with recombinant factor VIIa: A multicenter study
    • Hay CRM, Negrier C, Ludlam CA (1997) The treatment of bleeding in acquired hemophilia with recombinant factor VIIa: a multicenter study. Thromb Haemost 78: 3-7.
    • (1997) Thromb Haemost , vol.78 , pp. 3-7
    • Hay, C.R.M.1    Negrier, C.2    Ludlam, C.A.3
  • 20
    • 3042571427 scopus 로고    scopus 로고
    • Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: Data from the Italian registry of acquired hemophilia
    • Baudo F, de Cataldo F, Gaidano G (2004) Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia. Haematologica 89: 759-761.
    • (2004) Haematologica , vol.89 , pp. 759-761
    • Baudo, F.1    de Cataldo, F.2    Gaidano, G.3
  • 21
    • 0842285304 scopus 로고    scopus 로고
    • Acquired hemophilia: A critical bleeding syndrome
    • Baudo F, de Cataldo F (2004) Acquired hemophilia: a critical bleeding syndrome. Haematologica 89: 96-100.
    • (2004) Haematologica , vol.89 , pp. 96-100
    • Baudo, F.1    de Cataldo, F.2
  • 22
    • 34548319248 scopus 로고    scopus 로고
    • Treatment of acquired haemophilia with recombinant activated factor VIIa: A critical appraisal
    • Sumner MJ, Geldziler BD, Pedersen M, Seremetis S (2007) Treatment of acquired haemophilia with recombinant activated factor VIIa: a critical appraisal. Haemophilia 13: 451-461.
    • (2007) Haemophilia , vol.13 , pp. 451-461
    • Sumner, M.J.1    Geldziler, B.D.2    Pedersen, M.3    Seremetis, S.4
  • 24
    • 51249103799 scopus 로고    scopus 로고
    • Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors
    • Abshire T, Kenet G (2008) Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors. Haemophilia 14: 898-902.
    • (2008) Haemophilia , vol.14 , pp. 898-902
    • Abshire, T.1    Kenet, G.2
  • 26
    • 66349131573 scopus 로고    scopus 로고
    • Treatment of bleeding episodes occurring in patients with acquired haemophilia with FEIBA: The French experience
    • Goudemand J (2004) Treatment of bleeding episodes occurring in patients with acquired haemophilia with FEIBA: the French experience. Haemophilia 10: 14.
    • (2004) Haemophilia , vol.10 , pp. 14
    • Goudemand, J.1
  • 27
    • 1542360812 scopus 로고    scopus 로고
    • Treatment of acquired haemophilia with factor eight inhibitor bypassing activity
    • Sallah S (2004) Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia 10: 169-173.
    • (2004) Haemophilia , vol.10 , pp. 169-173
    • Sallah, S.1
  • 28
    • 24644480931 scopus 로고    scopus 로고
    • Acquired hemophilia: Management of bleeds and immune therapy to eradicate autoantibodies
    • Holme PA, Brosstad F, Tjonnfjord GE (2005) Acquired hemophilia: management of bleeds and immune therapy to eradicate autoantibodies. Haemophilia 11: 510-515.
    • (2005) Haemophilia , vol.11 , pp. 510-515
    • Holme, P.A.1    Brosstad, F.2    Tjonnfjord, G.E.3
  • 29
    • 77955030851 scopus 로고    scopus 로고
    • Baudo F, Collins P, Huth-Kühne A, Knoebl P, Lévesque H, Pascual M, Nemes L, Peerlinck K, Tengborn L (2009) Hemostatic therapy in acquired hemophilia: data from the European Acquired Hemophilia (EACH2) Registry. J Thromb Haemost 7 (suppl 2): abstr 058.
  • 30
    • 9044239679 scopus 로고    scopus 로고
    • Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: The results of an international survey
    • Hay CR, Lozier JN, Lee CA et al (1996) Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international survey. Thromb Haemost 75: 25-29.
    • (1996) Thromb Haemost , vol.75 , pp. 25-29
    • Hay, C.R.1    Lozier, J.N.2    Lee, C.A.3
  • 31
    • 0027216670 scopus 로고
    • DDAVP in acquired haemophilia A: Case report and review of the literature
    • Mudad R, Kane WH (1993) DDAVP in acquired haemophilia A: case report and review of the literature. Am J Haematol 43: 295-299.
    • (1993) Am J Haematol , vol.43 , pp. 295-299
    • Mudad, R.1    Kane, W.H.2
  • 32
    • 20444465906 scopus 로고    scopus 로고
    • Clinical heterogeneity of acquired hemophilia A: A description of 4 cases
    • Franchini M, Girelli D, Olivieri O et al (2005) Clinical heterogeneity of acquired hemophilia A: a description of 4 cases. Haematologica 90: e46-e49.
    • (2005) Haematologica , vol.90
    • Franchini, M.1    Girelli, D.2    Olivieri, O.3
  • 33
    • 0027379905 scopus 로고
    • A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies
    • Green D, Rademaker AW, Briet E (1993) A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 70: 753-757.
    • (1993) Thromb Haemost , vol.70 , pp. 753-757
    • Green, D.1    Rademaker, A.W.2    Briet, E.3
  • 34
    • 0030846488 scopus 로고    scopus 로고
    • Successful treatment of acquired hemophilia with oral immunosuppressive therapy
    • Shaffer LG, Phillips MD (1997) Successful treatment of acquired hemophilia with oral immunosuppressive therapy. Ann Intern Med 127: 206-209.
    • (1997) Ann Intern Med , vol.127 , pp. 206-209
    • Shaffer, L.G.1    Phillips, M.D.2
  • 35
    • 77955023672 scopus 로고    scopus 로고
    • Collins P, Baudo F, Huth-Kuhne A, Knoebl P, Levesque H, Marco P, Nemes L, Peerlinck K, Tengborn L (2009) First line immunosuppressive treatment for acquired factor VIII antibodies: results of the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost 7 (suppl 2): abstr 609.
  • 36
    • 1842373300 scopus 로고    scopus 로고
    • Acquired factor VIII inhibitors in non hemophilic patients
    • Söhngen D, Specker C, Bach D et al (1997) Acquired factor VIII inhibitors in non hemophilic patients. Ann Hematol 74: 89-93.
    • (1997) Ann Hematol , vol.74 , pp. 89-93
    • Söhngen, D.1    Specker, C.2    Bach, D.3
  • 37
    • 0024506424 scopus 로고
    • Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor
    • Lian EC, Larcada AF, Chiu AY (1989) Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann Intern Med 110: 774-778.
    • (1989) Ann Intern Med , vol.110 , pp. 774-778
    • Lian, E.C.1    Larcada, A.F.2    Chiu, A.Y.3
  • 38
    • 77955043455 scopus 로고    scopus 로고
    • Borg JY, Levesque H, for the SACHA study group (2007) Epidemiology and one-year outcomes in patients with acquired hemophilia in France. J Thromb Haemost 5(suppl 1): O-M-062.
  • 39
    • 0033826696 scopus 로고    scopus 로고
    • Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies
    • Petrovic M, Derom E, Baele G (2000) Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies. Haematologica 85: 895-896.
    • (2000) Haematologica , vol.85 , pp. 895-896
    • Petrovic, M.1    Derom, E.2    Baele, G.3
  • 40
    • 16844383435 scopus 로고    scopus 로고
    • Successful use of mycophenolate mofetil and prednisone in a 14-year-old girl with acquired hemophilia A
    • Eisert S, Mosler K, Laws HJ, Gobel U (2005) Successful use of mycophenolate mofetil and prednisone in a 14-year-old girl with acquired hemophilia A. Thromb Haemost 93: 792-793.
    • (2005) Thromb Haemost , vol.93 , pp. 792-793
    • Eisert, S.1    Mosler, K.2    Laws, H.J.3    Gobel, U.4
  • 41
    • 0029040859 scopus 로고
    • A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gamma globulin
    • Schwartz RS, Gabriel DA, Aledort LM, Green D, Kessler CM (1995) A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gamma globulin. Blood 86: 797-804.
    • (1995) Blood , vol.86 , pp. 797-804
    • Schwartz, R.S.1    Gabriel, D.A.2    Aledort, L.M.3    Green, D.4    Kessler, C.M.5
  • 42
    • 0035084797 scopus 로고    scopus 로고
    • Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitor: A 2-years review
    • Dykes AC, Walker ID, Lowe GD, Tait RC (2001) Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitor: a 2-years review. Haemophilia 7: 160-163.
    • (2001) Haemophilia , vol.7 , pp. 160-163
    • Dykes, A.C.1    Walker, I.D.2    Lowe, G.D.3    Tait, R.C.4
  • 43
    • 0030461712 scopus 로고    scopus 로고
    • Low response to high-dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitor
    • Crenier L, Ducobu J, des Grottes JM, Cerni J, Delaunoit C, Capel P (1996) Low response to high-dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitor. Br J Haematol 95: 750-753.
    • (1996) Br J Haematol , vol.95 , pp. 750-753
    • Crenier, L.1    Ducobu, J.2    Des Grottes, J.M.3    Cerni, J.4    Delaunoit, C.5    Capel, P.6
  • 45
    • 0033678879 scopus 로고    scopus 로고
    • New protocol for immune tolerance induction in acquired hemophilia
    • Nemes L, Pitlik E (2000) New protocol for immune tolerance induction in acquired hemophilia. Haematologica 85: 64-68.
    • (2000) Haematologica , vol.85 , pp. 64-68
    • Nemes, L.1    Pitlik, E.2
  • 46
    • 15244340408 scopus 로고    scopus 로고
    • Treatment of acquired hemophilia by the Bonn-Malmo protocol: Documentation of an in vivo immunomodulating concept
    • Zeitler H, Ulrich-Merzenich G, Hess L et al (2005) Treatment of acquired hemophilia by the Bonn-Malmo protocol: documentation of an in vivo immunomodulating concept. Blood 105: 2287-2293.
    • (2005) Blood , vol.105 , pp. 2287-2293
    • Zeitler, H.1    Ulrich-Merzenich, G.2    Hess, L.3
  • 47
    • 2942591961 scopus 로고    scopus 로고
    • Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia
    • Stasi R, Brunetti M, Stipa E, Amadori S (2004) Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. Blood 103: 4424-4428.
    • (2004) Blood , vol.103 , pp. 4424-4428
    • Stasi, R.1    Brunetti, M.2    Stipa, E.3    Amadori, S.4
  • 49
    • 33747109787 scopus 로고    scopus 로고
    • The efficacy of rituximab in the treatment of inhibitor-associated hemostatic disorder
    • Franchini M, Veneri D, Lippi G, Stenner R (2006) The efficacy of rituximab in the treatment of inhibitor-associated hemostatic disorder. Thromb Haemost 96: 119-125.
    • (2006) Thromb Haemost , vol.96 , pp. 119-125
    • Franchini, M.1    Veneri, D.2    Lippi, G.3    Stenner, R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.